PKA C-alpha/PKA C-beta Antibody (N-term) Blocking peptide

Artikelnummer: ABT-BP7013A
Artikelname: PKA C-alpha/PKA C-beta Antibody (N-term) Blocking peptide
Artikelnummer: ABT-BP7013A
Hersteller Artikelnummer: BP7013a
Alternativnummer: ABT-BP7013A-500UG
Hersteller: Abcepta
Kategorie: Proteine/Peptide
Alternative Synonym: cAMP-dependent protein kinase catalytic subunit alpha, PKA C-alpha, PRKACA, PKACA
cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase (AMPK), which transduces the signal through phosphorylation of different target proteins. The inactive holoenzyme of AMPK is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits of AMPK have been identified in humans. This protein, the alpha-catalytic subunit of AMPK, is a member of the Ser/Thr protein kinase family.
NCBI: 5566
UniProt: P17612
Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target-Kategorie: The synthetic peptide sequence used to generate the antibody -AP7013a was selected from the N-term region of human PKA C-alpha. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.